Evan Feinberg ^UDM

Evan Feinberg, as the Founder and CEO of Genesis Therapeutics, Inc., utilizes his extensive background in neuroscience, biotech, and finance to lead the company's innovative approach to drug discovery and development. With a Ph.D. from Stanford and experience as a deep learning consultant at Merck, Evan brings a unique combination of academic prowess and industry knowledge. Genesis Therapeutics employs advanced deep learning platforms, including graph convolutional neural networks, to revolutionize drug discovery, backed by a team of experienced drug hunters and a foundation in cutting-edge AI research.